Gaganjit Kaur: Nesfatin-1 as a Neuroprotective Target in Hyperhomocysteinemia-Induced VCID
Gaganjit Kaur, Associate Professor at Maharaja Agrasen University, shared a post on LinkedIn, about a recent article by Gaganjit Kaur et al., published in International Journal of Drug Delivery Technology adding:
“L-Methionine 1.7 g/kg; for 8 weeks, orally, induced hyperhomocysteinemia, and consequent VCID.
Nesfatin-1 is a neuropeptide, highly expressed in brain.
Nesfatin-1 is involved in appetite regulation, mitochondrial biogenesis and energy production, neuroprotection.
In addition Nesfatin-1 exhibits potent anti-neuroinflammatory, antioxidant and antiapoptotic effect․”
Tiltle: Nesfatin-1 Ameliorated Cognitive Functions In L-Methionine-Induced Vascular Cognitive Impairment and Dementia By Restoring Brain Mitochondrial Activity
Authors: Gaganjit Kaur, Sushma Devi, Manish Shukla, Manish Kumar, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, Maharaja Agrasen School of Pharmacy, Maharaja Agrasen University, Baddi, Solan, Himachal Pradesh, India
Stay updated on all scientific advances with Hemostasis Today.
-
May 8, 2026, 13:06Paula Dibo: New Evidence Connecting Anti PLA2R Antibodies and Thrombosis Risk
-
May 8, 2026, 12:58Ashutosh Kumar Pandey: IVC Filters Are Not a ‘Treatment’ for DVT
-
May 8, 2026, 12:57Aamir Saeed: Identifying Risk Factors for Bleeding After ERCP and Sphincterotomy
-
May 8, 2026, 12:42Alyaa Al-Mughairy: First Pediatric Case of Successful DOAC Treatment in a Clinical Setting
-
May 8, 2026, 09:25Athma Dias: Limitations of PT and APTT in Predicting Thrombotic Risk
-
May 8, 2026, 09:12Abhishek Kumar: New Horizons in Hemophilia B Treatment and Prevention
-
May 8, 2026, 08:19Augustina Isioma Ikusemoro: Thalassaemia is not Just a Blood Disorder – It is a Public Health Priority
-
May 8, 2026, 06:24Transforming Thrombosis Management With Antithrombotic Stewardship – Anticoagulation Forum
-
May 8, 2026, 06:03Risk-Stratified HRT Use Following VTE – NBCA